Brief: Liminal Biosciences Reports Q2 Net Loss Of $32.1 Million
16/08/2021 22:20
Aug 16 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
* LIMINAL BIOSCIENCES INC - NET LOSS WAS $32.1 MILLION FOR
Q2 OF
2021 COMPARED TO $27.8 MILLION FOR Q2 OF 2020
Source text for Eikon: ID:nCNWfv4lwa
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy